A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs
about
Specific in vivo knockdown of protein function by intrabodiesBiomaterials for mRNA delivery.Single domain antibodies for the knockdown of cytosolic and nuclear proteins.Intrabodies against the Polysialyltransferases ST8SiaII and ST8SiaIV inhibit Polysialylation of NCAM in rhabdomyosarcoma tumor cells.Rheumatoid arthritis vaccine therapies: perspectives and lessons from therapeutic ligand epitope antigen presentation system vaccines for models of rheumatoid arthritisSelf-replicating alphavirus RNA vaccines.Concise Review: Application of In Vitro Transcribed Messenger RNA for Cellular Engineering and Reprogramming: Progress and Challenges.mRNA Cancer Vaccines.Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems.Considerations for Producing mRNA Vaccines for Clinical Trials.The European Regulatory Environment of RNA-Based Vaccines.Synthetic mRNA: Production, Introduction into Cells, and Physiological Consequences.Trial Watch: Radioimmunotherapy for oncological indications.Vaccines 'on demand': science fiction or a future reality.Lipopolyplex potentiates anti-tumor immunity of mRNA-based vaccination.FLT3 Ligand as a Molecular Adjuvant for Naked RNA Vaccines.Engineering protein-protein devices for multilayered regulation of mRNA translation using orthogonal proteases in mammalian cells
P2860
Q26801077-F21A0F25-F9C7-4F20-B686-8517A5F82F49Q36271488-F96144AF-333A-4A5A-BFB0-7E2C1BED1C44Q36300378-AD2EBC19-9475-4673-91B5-CFECBF2DEBF1Q36370665-B3EDA38E-FAAA-4BAF-99D0-A662039703CAQ36673061-60A61D1B-C458-4A8A-BF6F-6C5698EAD5B4Q38255634-BDAECAD7-E268-4F16-8151-2A4A70981774Q38850538-2E0845C4-71EF-488E-BB75-D86EAB289C6BQ39013357-E507CB37-1369-42C2-B0E6-916AE66CF293Q39091854-86C1E884-24FF-4736-BC42-F380D02226E2Q39093225-16D510E8-FA9E-4313-A32E-9358D1E5B401Q40405913-E5D1C1DE-83D5-4015-B008-249565B2E2B4Q40654970-9CBC6012-2DC4-4F09-B4C7-84079DCDF860Q43104064-C0458528-427D-4349-851B-9ACC4C42CCFCQ44095960-5C6E522C-FFAB-4BD3-9171-B10D389D1A42Q50454256-AEAC9A37-87A7-482C-9D69-A8150CC27122Q53092567-ABB7BA80-76D4-487C-8DE4-9DC90F9319E4Q57804750-44FC139C-BFB1-4AA3-A74B-731CDB86BBEA
P2860
A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A development that may evolve ...... otide-based vaccines and drugs
@en
type
label
A development that may evolve ...... otide-based vaccines and drugs
@en
prefLabel
A development that may evolve ...... otide-based vaccines and drugs
@en
P2860
P356
P1476
A development that may evolve ...... otide-based vaccines and drugs
@en
P2093
Andreas Theß
Karl-Josef Kallen
P2860
P356
10.1177/2051013613508729
P577
2014-01-01T00:00:00Z